Chinese authorities have released a list of 33 drugs for centralized procurement in large quantities by public healthcare institutions amid their steady efforts to reform the drug procurement system and make medicines more affordable to patients.（图片来源：视觉中国）【知识点】2019年1月1日，国务院办公...
The host grasps the medicine and the medical instrument purchase service, for the patient strictly the drugs quality pass, most makes I admire, he ever does not take the sales commission, only for has a clear conscience. 相关内容 a为了使孩子能够健康成长 In order to enable the child the heal...
"On average, around 6.5 companies have been chosen for every type of medicine, suggesting that supplies of these drugs are becoming more diversified and stable," said the administration. This round of centralized procurement has covered a number of drugs for common and ch...
The Chinese government implemented the first round of National Centralized Drug Procurement (NCDP) pilot (so-called “4 + 7” policy) in mainland China in 2019. This study aims to examine the impact of “4 + 7” policy on the price of policy-related drugs. Methods This study use...
Exploratory analysis and trend measures were performed for the variables for mapping and characterizing the purchases of non-market approved drugs.614 (0.14%) purchases in ten years corresponding to 64 unlicensed medicines - some of which had orphan drug status - and 48 different active substances;...
The combined number of drugs purchased through China's national and provincial drug bulk-buying schemes is expected to grow to 500, according to the National Healthcare Security Administration. Two rounds of unified drug procurement were completed in 2023, with 80 medicines selected and an average ...
China's National Healthcare Security Administration (NHSA) has organized nine rounds of bulk buying for drugs, on average more than halving the prices of 374 different medicines. The scheme has also reduced the prices of eight high-value medical consumables, including coronary stents and artificial...
This study is the first to empirically explore the impact and mechanism of VBP policy on the consumption of drugs for chronic disease from the perspectives of demand release and policy assessment inducing. China’s VBP practice has significantly increased cardiovascular drug utilization among lower-inco...
Centralized procurement of anticancer drugs at provincial level in China PENG Hong-yu1, LI Chen1, ZHANG Rui-zhi2, 1. School of Health Sciences, Wuhan University, Wuhan, Hubei Province 430071, China More Information Abstract A government-led centralized procurement pattern for purchasing medicines ...
Hemandez and his colleagues reported that discounts increased from 40% in 2007 to 76% in 2018 in Medicaid and from 23% to 51% in other payers, offsetting 62% of increases in list prices for drugs.7 In Europe, discounts on medicines, granted by the pharmaceutical industry to public payers...